Observational studyClinical drug investigation2014

Candesartan cilexetil 32 mg/hydrochlorothiazide 25 mg in unselected patients with high or very high cardiovascular risk: efficacy, safety, and metabolic impact.

Peter Bramlage et al.PubMed ↗Publisher ↗

No numbers read from the abstract.